13F HOLDINGS REPORT
Casdin Capital, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000919574-23-006405
Total Value
$903.5M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAREPTA THERAPEUTICS INC | SRPT | 1,010,330 | $122.5M | 13.55% |
| 2 | BIOLIFE SOLUTIONS INC | BLFS | 7,780,000 | $107.4M | 11.89% |
| 3 | EQRX INC | 26886C107 | 39,527,669 | $87.8M | 9.71% |
| 4 | STRUCTURE THERAPEUTICS INC | GPCR | 1,258,166 | $62.0M | 6.86% |
| 5 | RELAY THERAPEUTICS INC | RLAY | 6,923,574 | $58.2M | 6.44% |
| 6 | REVOLUTION MEDICINES INC | RVMDW | 1,810,000 | $50.1M | 5.55% |
| 7 | VERVE THERAPEUTICS INC | 92539P101 | 2,954,710 | $39.2M | 4.34% |
| 8 | INTELLIA THERAPEUTICS INC | NTLA | 1,178,075 | $37.3M | 4.12% |
| 9 | ALNYLAM PHARMACEUTICALS INC | ALNY | 200,000 | $35.4M | 3.92% |
| 10 | EXACT SCIENCES CORP | 30063P105 | 459,450 | $31.3M | 3.47% |
| 11 | SOMALOGIC INC | 83444K105 | 12,604,275 | $30.1M | 3.33% |
| 12 | PLIANT THERAPEUTICS INC | PLRX | 1,577,108 | $27.3M | 3.03% |
| 13 | DENALI THERAPEUTICS INC | DNLI | 1,300,000 | $26.8M | 2.97% |
| 14 | MIRATI THERAPEUTICS INC | 60468T105 | 498,427 | $21.7M | 2.40% |
| 15 | BLUEPRINT MEDICINES CORP | 09627Y109 | 371,378 | $18.7M | 2.06% |
| 16 | TENAYA THERAPEUTICS INC | TNYA | 6,381,377 | $16.3M | 1.80% |
| 17 | TANGO THERAPEUTICS INC | TNGX | 1,307,349 | $14.7M | 1.63% |
| 18 | BEAM THERAPEUTICS INC | BEAM | 570,000 | $13.7M | 1.52% |
| 19 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,033,811 | $13.2M | 1.46% |
| 20 | GENEDX HOLDINGS CORP | WGSWW | 3,095,511 | $11.3M | 1.25% |
| 21 | ABCELLERA BIOLOGICS INC | ABCL | 2,360,129 | $10.9M | 1.20% |
| 22 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 1,035,859 | $8.6M | 0.96% |
| 23 | AVIDITY BIOSCIENCES INC | 05370A108 | 1,250,000 | $8.0M | 0.88% |
| 24 | 2SEVENTY BIO INC | 901384107 | 2,023,913 | $7.9M | 0.88% |
| 25 | CENTURY THERAPEUTICS INC | IPSC | 3,206,380 | $6.4M | 0.71% |
| 26 | MAXCYTE INC | MXCT | 1,890,000 | $5.9M | 0.65% |
| 27 | FATE THERAPEUTICS INC | FATE | 2,050,000 | $4.3M | 0.48% |
| 28 | ALNYLAM PHARMACEUTICALS INC | ALNY | 20,000 | $3.5M | 0.39% |
| 29 | PRIME MEDICINE INC | PRME | 367,175 | $3.5M | 0.39% |
| 30 | STANDARD BIOTOOLS INC | LAB | 1,200,000 | $3.5M | 0.39% |
| 31 | ILLUMINA INC | ILMN | 25,000 | $3.4M | 0.38% |
| 32 | ILLUMINA INC | ILMN | 25,000 | $3.4M | 0.38% |
| 33 | SANA BIOTECHNOLOGY INC | SANA | 750,000 | $2.9M | 0.32% |
| 34 | MONTE ROSA THERAPEUTICS INC | GLUE | 510,882 | $2.4M | 0.27% |
| 35 | ABSCI CORPORATION | ABSI | 973,260 | $1.3M | 0.14% |
| 36 | EXSCIENTIA PLC | 30223G102 | 213,900 | $966,828 | 0.11% |
| 37 | CODEXIS INC | CDXS | 300,000 | $567,000 | 0.06% |
| 38 | SINGULAR GENOMICS SYSTEMS IN | 82933R100 | 1,323,885 | $504,400 | 0.06% |
| 39 | LIANBIO | LIANY | 206,415 | $307,558 | 0.03% |
| 40 | KRONOS BIO INC | 50107A104 | 123,839 | $160,991 | 0.02% |